The Relationship between Oral Microbiome and SARS-CoV-2
Journal of Pharmaceutical Research International · pp. 73–87 · Published 28 Dec 2021
10.9734/jpri/2021/v33i61A35118Abstract
The oral microbiome represents an important part of the human microbiome. It has an important function to protect against the colonization of extrinsic bacteria, affecting systemic health. On the other hand, the most common oral diseases such as caries, gingivitis, and periodontitis, are based on microorganisms. After the gut microbiome, the oral microbiome is the second largest microbial population in the body. It has the potential to affect the onset and progression of a variety of localized and systemic disorders, including viral infections, especially those that enter the body through the oropharynx. Pandemics like SARS and coronavirus disease 2019 (COVID-19) have impacted negatively on economies and people around the world in recent years, making viral infection one of the most common and dangerous health problems. Despite being one of many respiratory viruses that use the oropharynx as their primary replication site, the novel pandemic human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease has yet to be determined. PubMed, Medline, Google Scholar, Science Direct, Scopus, and Web of Science databases were among the search engines used up to December 1, 2021. For published data, search terms included 'Microbiome', 'COVID-19,' ' Oral Microbiome changes in COVID-19,' dysbiosis in COVID-19', or 'SARS-CoV-2'. This concise review aimed to see if there was a link between the oral microbiome and SARS-CoV-2.
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
1
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.